EichorEICHOR
Study identifier: NCT06307665 Synced from ClinicalTrials.gov · August 07, 2026
● Study status: Recruiting

Evaluating the Efficacy and Safety of PT027 Compared With PT007 Administered As Needed in Participants 12 to < 18 Years of Age With Asthma

Condition: Asthma  ·  Sponsor: AstraZeneca

PhasePhase 3
Planned participants440
Who can joinAll sexes, 12 Years to 17 Years
Healthy volunteersNo

Sponsor, CRO or site team? See where this study is running → — listed sites, countries and recruiting context. Everything below is written for patients and caregivers.

About this study

The purpose of this study is to compare the effect of budesonide/albuterol metered-dose inhaler (BDA MDI) with albuterol sulfate metered-dose inhaler (AS MDI), both administered as needed, on the annualized rate of severe asthma exacerbations in adolescents with a documented clinical diagnosis of asthma and at least one severe exacerbation in the prior year.

This description comes directly from the study's public registry record.

Talk to the study team

AstraZeneca Clinical Study Information Center  ·  1-877-240-9479  ·  information.center@astrazeneca.com

Always discuss trial participation with your own doctor first.

Locations (144)

Research SiteAnchorage, Alaska, United StatesRecruiting
Research SiteGilbert, Arizona, United StatesRecruiting
Research SitePhoenix, Arizona, United StatesRecruiting
Research SiteLittle Rock, Arkansas, United StatesCompleted
Research SiteHuntington Beach, California, United StatesNot Yet Recruiting
Research SiteHuntington Beach, California, United StatesNot Yet Recruiting
Research SiteLong Beach, California, United StatesRecruiting
Research SiteLong Beach, California, United StatesRecruiting
Research SiteMadera, California, United StatesNot Yet Recruiting
Research SiteMission Viejo, California, United StatesRecruiting
Research SiteMoreno Valley, California, United StatesRecruiting
Research SiteOrange, California, United StatesRecruiting

+ 132 more locations — full list on the registry record.

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice. By subscribing you agree to our Terms of Use and Privacy Policy.

Look up another condition
Look up another city
Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →
Eichor
Clinical intelligence from public evidence
Use of Eichor is governed by our Terms of Use · Privacy Policy
© 2026 Biomedistats LLC (dba Eichor)

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06307665